Clinical Trial Update: Study of IMC-11F8 in Participants With Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study of IMC-11F8 in participants with metastatic colorectal cancer has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• IMC-11F8

Snippet

Sponsor: Eli Lilly and Company | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-01-29